Blood Clot Risk Eight Times Higher From Covid Than AstraZeneca Vaccine, Study Finds
The title of this post, is the same as that of this article on The Telegraph.
This is the first two paragraphs.
The risk of a rare brain clot from coronavirus is approximately eight times greater the risk presented by the AstraZeneca jab, a University of Oxford study has found.
The research, which is yet to be peer-reviewed, and compared blood clot rates among 500,000 coronavirus patients with data from the roll-out of 34 million vaccine doses across Europe.
I will certainly be having my second AstraZeneca jab next Monday.
This press release on the Astra-Zeneca web site is entitled Oxford Phase III trials interim analysis results published in The Lancet.
This is an extract.
In addition to the Oxford led programme, AstraZeneca is conducting a large study in the US and globally. In total, Oxford University and AstraZeneca expect to enrol more than 60,000 participants globally.
The Telegraph article also says this.
The incidence of rates for cerebral venous thrombosis (CVT) – a rare blood clot on the brain – is 39 per million coronavirus patients, while it is five per million recipients of the AstraZeneca vaccine.
Note that five per million is 0.3 per 60,000.
Any participant, who got a blood clot in the AstraZeneca Phase III trial would have been a very unlucky person.
Those who say, that the AstraZeneca vaccine was rushed and that many more people should participated in the trials may have a point.
But countering that is my belief that data analysis has improved so much in the last twenty years that all the data on all the vaccines has been so thoroughly analysed by some of the best data analysts and analytic software, that most more common problems have been identified.
The Anonymous Widower 